skip to main content
LOTERRE

LOTERRE

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

Langue des données

| español English
Aide à la recherche

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > piperidines > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidone > (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione

Terme préférentiel

(R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione  

Concept(s) générique(s)

Synonyme(s)

  • (7R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
  • (7R)-7-[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidine-1-carbonyl]-1,3-diazepane-2,4-dione

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-Z22Q5V1D-P

Télécharger ce concept:

RDF/XML TURTLE JSON-LD Dernière modif. 25/03/2022